| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Benefit Versus Risk for Oral, Inhaled, and Nasal Glucocorticosteroids
|
Mortimer, Kevin J.
|
|
2005
|
25 |
3 |
p. 523-539
17 p.
|
artikel
|
| 2 |
Comparative Pharmacology, Bioavailability, Pharmacokinetics, and Pharmacodynamics of Inhaled Glucocorticosteroids
|
Hübner, Melanie
|
|
2005
|
25 |
3 |
p. 469-488
20 p.
|
artikel
|
| 3 |
Contents
|
|
|
2005
|
25 |
3 |
p. v-viii
nvt p.
|
artikel
|
| 4 |
Effects of Glucocorticoids on the Hypothalamic-Pituitary-Adrenal Axis in Children and Adults
|
Gulliver, Tanya
|
|
2005
|
25 |
3 |
p. 541-555
15 p.
|
artikel
|
| 5 |
Effects of Glucocorticosteroids on the Skin and Eye
|
Beltrani, Vincent S.
|
|
2005
|
25 |
3 |
p. 557-580
24 p.
|
artikel
|
| 6 |
Forthcoming Issues
|
|
|
2005
|
25 |
3 |
p. ix-
1 p.
|
artikel
|
| 7 |
Glucocorticosteroids in Allergic Inflammation
|
Skoner, David
|
|
2005
|
25 |
3 |
p. xi-xii
nvt p.
|
artikel
|
| 8 |
Glucocorticosteroids in Allergic Inflammation: Clinical Benefits in Allergic Rhinitis, Rhinosinusitis, and Otitis Media
|
van Cauwenberge, P.
|
|
2005
|
25 |
3 |
p. 489-509
21 p.
|
artikel
|
| 9 |
Index
|
|
|
2005
|
25 |
3 |
p. 613-620
8 p.
|
artikel
|
| 10 |
Initiation, Dose Reduction, and Duration of Inhaled Corticosteroid Therapy
|
O'Byrne, Paul M.
|
|
2005
|
25 |
3 |
p. 511-521
11 p.
|
artikel
|
| 11 |
Molecular Mechanisms and Cellular Effects of Glucocorticosteroids
|
Barnes, Peter J.
|
|
2005
|
25 |
3 |
p. 451-468
18 p.
|
artikel
|
| 12 |
Positioning of Glucocorticosteroids in Asthma and Allergic Rhinitis Guidelines (Versus Other Therapies)
|
Joos, Guy F.
|
|
2005
|
25 |
3 |
p. 597-612
16 p.
|
artikel
|
| 13 |
Steroid Phobia and Adherence—Problems, Solutions, Impact on Benefit/Risk Profile
|
Rao, Vivek U.
|
|
2005
|
25 |
3 |
p. 581-595
15 p.
|
artikel
|
Tijdschrift beschrijving